English Français

Medexus Pharmaceuticals, Inc. Medexus Pharmaceuticals, Inc.

  • English
  • About
    • Overview
    • Growth Strategy
    • Management Team
    • Board of Directors
  • Our Portfolio
    • Overview
    • Canadian Product Portfolio
    • US Product Portfolio
  • News
    • Press Releases
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Presentation
    • Financial Results
    • Stock Data
    • Governance
    • SEDAR+
  • Contact
  • Careers
  • English
  • Français

Press Releases

News

News

  • Press Releases
  • Events
Jun 15, 2023 7:25am EDT

FDA Accepts for Review Medexus's IXINITY Supplemental Biological License Application for Pediatric Patients

Jun 14, 2023 5:30pm EDT

Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2023 Conference Call

Jun 13, 2023 7:25am EDT

Medexus Highlights Data on Trecondyv (Treosulfan) Presented at MDS 2023

Jun 01, 2023 5:30pm EDT

Medexus to Participate in the LD Micro Invitational XIII

May 10, 2023 5:30pm EDT

Medexus Announces Normal Course Issuer Bid, or NCIB, for Its Convertible Debentures

May 09, 2023 6:21pm EDT

Medexus Demonstrates Cost-Effectiveness of Gleolan-Guided Surgery for High-Grade Glioma

Apr 18, 2023 5:30pm EDT

Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference

Apr 11, 2023 7:25am EDT

Medexus Expects Record Revenue for Fiscal Year 2023 and Provides Business Update

Mar 22, 2023 7:20am EDT

Medexus Announces New License Deal for Topical Terbinafine

Mar 08, 2023 5:00pm EST

Medexus Announces US$58.5 million in New Credit Facilities

RSS
  • Previous
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...15
    Next
    © 2023 Medexus Pharmaceuticals, Inc.
    All Rights Reserved.
    Facebook Facebook
    Privacy Policy Disclaimer Sitemap

    Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.